FOSTER CITY, Calif.-Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, has announced new compensation terms involving equity awards to 16 newly hired employees. The company has granted stock options for a total of 744,000 shares of common stock, alongside restricted stock units (RSUs) representing 372,000 shares. Granted on June 17, 2025, the stock options come with an exercise price of $1.45 per share, matching the closing price on the grant date. These options have a ten-year term, with vesting over four years. Similarly, the RSUs will vest annually over four years. These awards were sanctioned by Geron's Compensation Committee in line with Nasdaq Listing Rule 5635(c)(4) and fall under the company's 2018 Inducement Award Plan.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。